New York Codes, Rules and Regulations
Title 10 - DEPARTMENT OF HEALTH
Chapter I - State Sanitary Code
Part 12 - Maternal And Child Health
Protection of Infants and Children Against Hazards
Section 12.13 - Determination of blood group and rh type and administration of rh immune globulin

Current through Register Vol. 46, No. 39, September 25, 2024

(a) It shall be the duty of the physician, licensed midwife or nurse practitioner attending a pregnant woman to take or cause to be taken a sample of her blood at the time of first examination or if this has not been done, as soon thereafter as practicable and prior to the time of delivery or other termination of pregnancy, whether induced or spontaneous. If the sample has not been taken and the pregnancy terminates as a result of an emergency, it shall be taken at the time of termination of pregnancy. Such sample shall be submitted to an approved laboratory for the determination of blood group and Rh type.

(b) It shall further be the duty of the attending physician, licensed midwife or nurse practitioner to evaluate every such patient for the risk of sensitization to Rho (D) antigen and if the use of Rh immune globulin is indicated, and the patient consents, to cause an appropriate dosage thereof to be administered to her as soon as possible within 72 hours after delivery or other termination of pregnancy, whether induced or spontaneous.

Disclaimer: These regulations may not be the most recent version. New York may have more current or accurate information. We make no warranties or guarantees about the accuracy, completeness, or adequacy of the information contained on this site or the information linked to on the state site. Please check official sources.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.